Bank of Montreal’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-16,163
Closed -$284K – 4230
2022
Q1
$284K Sell
16,163
-15,433
-49% -$266K ﹤0.01% 3224
2021
Q4
$622K Buy
31,596
+1,112
+4% +$22.4K ﹤0.01% 2234
2021
Q3
$648K Buy
+30,484
New +$653K ﹤0.01% 2732
2020
Q4
– Sell
-44,041
Closed -$792K – 5019
2020
Q3
$792K Buy
+44,041
New +$789K ﹤0.01% 2089
2020
Q2
– Sell
-46,388
Closed -$681K – 4709
2020
Q1
$681K Buy
46,388
+2,522
+6% +$41.3K ﹤0.01% 1852
2019
Q4
$765K Sell
43,866
-5,799
-12% -$95.2K ﹤0.01% 2433
2019
Q3
$750K Buy
49,665
+15,670
+46% +$251K ﹤0.01% 2207
2019
Q2
$573K Buy
33,995
+7,442
+28% +$123K ﹤0.01% 2345
2019
Q1
$455K Buy
26,553
+24,072
+970% +$416K ﹤0.01% 2349
2018
Q4
$37K Sell
2,481
-11,291
-82% -$199K ﹤0.01% 3408
2018
Q3
$281K Buy
+13,772
New +$274K ﹤0.01% 2582
2015
Q3
– Sell
-2,700
Closed -$76K – 4064
2015
Q2
$76K Buy
+2,700
New +$74.8K ﹤0.01% 2853

Other funds holding HQL

Bank of Montreal's HQL Position: Q2 2022 in Review

Bank of Montreal sold out of abrdn Life Sciences Investors (HQL) in Q2 2022, closing a stake of 16,163 shares — an estimated $284K sold.

Bank of Montreal first reported a position in HQL in Q2 2015 and held it in 12 quarters. The position peaked at $792K in Q3 2020. 65 funds tracked by Wall St. Rank hold HQL as of Q2 2022.

  • Bank of Montreal reported no remaining abrdn Life Sciences Investors position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 16,163 abrdn Life Sciences Investors shares in Q2 2022, an estimated $284K.
  • Bank of Montreal first reported a position in abrdn Life Sciences Investors in Q2 2015 and held it in 12 quarters.
  • Bank of Montreal's abrdn Life Sciences Investors position peaked at $792K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.